Pricing Log in Create free account

Ensysce Biosciences, Inc. (ENSC) vs Passage Bio, Inc. (PASG)

Ensysce Biosciences, Inc. and Passage Bio, Inc. are both Biotechnology companies. Ensysce Biosciences, Inc. and Passage Bio, Inc. are of similar size ($11.6M and $11.6M). Passage Bio, Inc. has the higher net margin (0.00% vs −280.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Passage Bio, Inc. leads on 7 and Ensysce Biosciences, Inc. on 4.

Valuation

Metric ENSC PASG Biotechnology median
P/E n/m n/m 8.50
P/S 1.51 n/m 9.71
P/B n/m 2.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.34 0.64
EV/Sales 1.54 n/m 9.21
Earnings yield (530.77%) (325.29%) (33.15%)
Free cash flow yield (130.64%) (326.67%) (25.50%)

Profitability

Metric ENSC PASG Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (281.32%) 0.00% 0.00%
Net margin (280.49%) 0.00% 0.00%
Free cash flow margin (196.76%) 0.00% 0.00%
Return on equity (1,295.01%) (169.09%) (56.36%)
Return on assets (295.92%) (69.20%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENSC PASG Biotechnology median
Revenue growth (TTM) (39.29%) — 6.02%
EPS growth (last fiscal year) 65.24% 32.94% 30.26%
Revenue growth, 5-year CAGR 5.21% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENSC PASG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.70 1.22 4.72
Net debt to EBITDA 0.42 0.96 0.96

Dividend

Metric ENSC PASG Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ENSC PASG Biotechnology median
Market cap 11.64m 11.59m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack